265 related articles for article (PubMed ID: 10845730)
41. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
[TBL] [Abstract][Full Text] [Related]
43. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy.
Nakken KO; Eriksson AS; Lossius R; Johannessen SI
Seizure; 2003 Jan; 12(1):42-6. PubMed ID: 12495648
[TBL] [Abstract][Full Text] [Related]
44. Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients.
Somerville ER; McLaughlin DB; Robinson MK; Berkovic SF
Epilepsy Behav; 2007 Nov; 11(3):338-42. PubMed ID: 17851135
[TBL] [Abstract][Full Text] [Related]
45. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J
Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of levetiracetam in partial seizures.
Devinsky O; Elger C
Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
[TBL] [Abstract][Full Text] [Related]
47. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
Lambrechts DA; Sadzot B; van Paesschen W; van Leusden JA; Carpay J; Bourgeois P; Urbain E; Boon PA
Seizure; 2006 Sep; 15(6):434-42. PubMed ID: 16893660
[TBL] [Abstract][Full Text] [Related]
49. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
50. Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy.
Specchio LM; Boero G; Specchio N; De Agazio G; De Palo A; de Tommaso M; Beghi E; La Neve A
Seizure; 2006 Mar; 15(2):112-6. PubMed ID: 16406697
[TBL] [Abstract][Full Text] [Related]
51. Preliminary efficacy of levetiracetam in monotherapy.
Ben-Menachem E
Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy.
Kanemura H; Sano F; Tando T; Sugita K; Aihara M
Brain Dev; 2013 May; 35(5):386-91. PubMed ID: 22871391
[TBL] [Abstract][Full Text] [Related]
53. Levetiracetam: a long-term follow-up study of efficacy and safety.
Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
[TBL] [Abstract][Full Text] [Related]
54. Tolerability and efficacy of oral loading of levetiracetam.
Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
[TBL] [Abstract][Full Text] [Related]
55. Retrospective study of the use of levetiracetam in childhood seizure disorders.
Koukkari MW; Guarino EJ
J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
57. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
Dooley M; Plosker GL
Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
[TBL] [Abstract][Full Text] [Related]
58. Levetiracetam in refractory pediatric epilepsy.
Wheless JW; Ng YT
J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
[TBL] [Abstract][Full Text] [Related]
59. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects.
Rémi C; Lorenzl S; Vyhnalek B; Rastorfer K; Feddersen B
J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):371-7. PubMed ID: 25313924
[TBL] [Abstract][Full Text] [Related]
60. The SKATE study: interim analysis.
Olwen GO
Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
